DEXTROMETHORPHAN HYDROBROMIDE Recall D-0049-2025
Description: Guaifenesin Dextromethorphan Syrup, 200 mg/20mg per 10 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7135-72
DEXTROMETHORPHAN HYDROBROMIDE Recall D-0049-2025 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0049-2025 |
| Event ID | 95705 |
| Brand | CHEST CONGESTION RELIEF |
| Generic Name | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Manufacturer | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN |
| Active Substance | DEXTROMETHORPHAN HYDROBROMIDE GUAIFENESIN |
| Drug Route | ORAL |
| Distribution | Nationwide within the United States |
| Quantity | N/A |
| Recall Reason | Failed Impurity/Degradation Specifications |
| Drug Classification | Class II |
| Drug Code Info | 20241127 |
| Product NDC | 0904-7135 |
| Product NUI | N0000193956 N0000008867 N0000009560 |
| Drug UPC | 0309047135721 |
| Pharma Class (PE) | Decreased Respiratory Secretion Viscosity [PE] |
| Pharma Class (EPC) | Expectorant [EPC] |
| Recall Initiation Date | 20241107 |
| Report Date | 20241127 |
| Classification Date | 20241118 |
| Address | 341 Mason RdN/A La Vergne, TN 37086-3606 United States |
| Recalling Firm | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |
| Initial Notification | Letter |
| Unique Ingredient Identifier | 9D2RTI9KYH 495W7451VQ |
| Drug Application Number | M012 |
| Structured Product Labeling (SPL ID) | 1beb7a5c-f75a-40c7-9713-b25b86e7c9a6 |
| Structured Product Labeling (SPL Set ID) | 6e0badf4-69ee-4728-938b-23f2eb1bfc79 |
| Similar To |